Literature DB >> 2156190

The glutamate receptor of the Qp-type activates protein kinase C and is regulated by protein kinase C.

O J Manzoni1, F Finiels-Marlier, I Sassetti, J Blockaert, C le Peuch, F A Sladeczek.   

Abstract

In striatal neurons in primary culture quisqualate potently stimulated the formation of inositol phosphates via a metabotropic receptor we recently termed Qp in order to distinguish it from the classical ionotropic quisqualate receptor termed Qi. Here we show that 10 microM of quisqualate activated in a rapid and transient manner protein kinase C as assessed by its translocation from the cytosolic to the membrane fraction. As 10 microM alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA), the Qi specific agonist, was without effect, this translocation was most probably mediated by the Qp receptor. Phorbol 12,13-dibutyrate blocked in a dose-dependent manner the Qp receptor-induced inositol phosphate formation (IC50 = 2 +/- 0.4 nM). The inactive ester 4 alpha-phorbol-12,13-didecanoate was without effect. Very low concentrations of staurosporine completely reversed the phorbol 12,13-dibutyrate-induced blockade (IC50 = 2.2 +/- 1.3 nM). It can therefore be concluded that the Qp receptor is able to activate protein kinase C and that the activity of this metabotropic receptor is regulated by protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156190     DOI: 10.1016/0304-3940(90)90553-l

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Characterization of a metabotropic glutamate receptor: direct negative coupling to adenylyl cyclase and involvement of a pertussis toxin-sensitive G protein.

Authors:  L Prezeau; O Manzoni; V Homburger; F Sladeczek; K Curry; J Bockaert
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  Opposing effects of protein kinase C and protein kinase A on metabotropic glutamate receptor signaling: selective desensitization of the inositol trisphosphate/Ca2+ pathway by phosphorylation of the receptor-G protein-coupling domain.

Authors:  A Francesconi; R M Duvoisin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Possible role of protein kinase C in the sensitization of primate spinothalamic tract neurons.

Authors:  Q Lin; Y B Peng; W D Willis
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

Review 4.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

Review 5.  The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats.

Authors:  T J Coderre
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

6.  Actions of agonists of metabotropic glutamate receptors on synaptic transmission and transmitter release in the olfactory cortex.

Authors:  G G Collins
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

7.  Phosphorylation and feedback regulation of metabotropic glutamate receptor 1 by calcium/calmodulin-dependent protein kinase II.

Authors:  Dao-Zhong Jin; Ming-Lei Guo; Bing Xue; Eugene E Fibuch; Eun Sang Choe; Li-Min Mao; John Q Wang
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

8.  Characterization of metabotropic glutamate receptor-mediated facilitation of N-methyl-D-aspartate depolarization of neocortical neurones.

Authors:  S Rahman; R S Neuman
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

9.  Transduction mechanism for glutamate-induced potassium current in neurones of the mollusc Planorbarius corneus.

Authors:  S A Gapon; L G Magazanik
Journal:  J Physiol       Date:  1992-09       Impact factor: 5.182

10.  Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence.

Authors:  M E Fundytus; T J Coderre
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.